Vaxigriptetra

Vaxigriptetra is a quadrivalent influenza vaccine designed to protect against four influenza virus strains. It helps reduce the risk of seasonal flu and related complications. This vaccine is suitable for adults and children from 6 months of age. Store between 2°C and 8°C to maintain potency.

Vaxigriptetra is used to provide active immunization against influenza caused by four specific virus strains. It is administered annually as part of seasonal flu prevention. The vaccine is intended for individuals seeking protection from common flu viruses during peak seasons. It does not treat existing infections but helps build immunity.

After vaccination, the immune system recognizes and responds to the inactivated virus components in the vaccine. This process may lead to mild, temporary effects such as soreness at the injection site or mild fever. Most reactions are short-lived and resolve within a few days.

Keep the vaccine refrigerated between 2°C and 8°C and protect it from light. Do not freeze. Ensure the vaccine is administered by a healthcare professional. Discuss any allergies, especially to eggs or previous flu vaccines, with a provider before use. Do not use if the vial or syringe is damaged.

Vaxigriptetra may interact with immunosuppressive therapies, reducing its effectiveness. Avoid receiving other vaccines within 14 days unless directed by a healthcare provider. Consult a doctor if taking medications that affect the immune system, such as corticosteroids. Alcohol does not directly interact but may impair immune response.